2007•Expert Review of Obstetrics & GynecologyRequires access

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Wesley H. Clark, Caitlin S. Shannon, Beverly Winikoff

Open publisher page 36 citations

Abstract

Misoprostol – a drug developed and approved originally for the prevention of gastric ulcers – has shown itself to be safe, effective and acceptable for uterine evacuation in the context of induced abortion and failed pregnancy. Many practitioners consider it to be the treatment of choice for these indications, despite the fact that, as of now, nearly all such use remains off-label. In the absence of regulatory guidelines, a great deal of research on misoprostol for uterine evacuation has been conducted – research that both suggests desirable approaches to treatment and highlights areas of continuing uncertainty. It is hoped that summarizing these data can both assist practitioners in their work and spur movement towards optimized regimens and the eventual registration of misoprostol for these uses.

About this research paper

What this paper is about

Misoprostol – a drug developed and approved originally for the prevention of gastric ulcers – has shown itself to be safe, effective and acceptable for uterine evacuation in the context of induced abortion and failed pregnancy. Many practitioners consider it to be the treatment of choice for these indications, despite the fact that, as of now, nearly all such use remains off-label. In the absence of regulatory guidelines, a great deal of research on misoprostol for uterine evacuation has been conducted – research that both suggests desirable approaches to treatment and highlights areas of continuing uncertainty. It is hoped that summarizing these data can both assist practitioners in their work and spur movement towards optimized regimens and the eventual registration of misoprostol for these uses.

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Misoprostol – a drug developed and approved originally for the prevention of gastric ulcers – has shown itself to be safe, effective and acceptable for uterine evacuation in the context of induced abortion and failed pregnancy. Many practitioners consider it to be the treatment of choice for these indications, despite the fact that, as of now, nearly all such use remains off-label. In the absence of regulatory guidelines, a great deal of research on misoprostol for uterine evacuation has been conducted – research that both suggests desirable approaches to treatment and highlights areas of continuing uncertainty. It is hoped that summarizing these data can both assist practitioners in their work and spur movement towards optimized regimens and the eventual registration of misoprostol for these uses.

Key concepts: Misoprostol, Medicine, Context (archaeology), Abortion, Pregnancy, Obstetrics, Gynecology, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Misoprostol for uterine evacuation in induced abortion and pregnancy failure — Research Paper | ScholarLens